Buy Moxinclav CV-625 Wholesale South Korea Supply to Japan China East Asia

Wholesale Moxinclav CV-625 | Strategic Bulk Supply & East Asian Export

Sky High Medex is a specialized pharmaceutical exporter serving the South Korean market and the broader East Asian region with Moxinclav CV-625 Tablets (Amoxicillin & Potassium Clavulanate). We provide licensed medical distributors, dental networks, and hospital procurement groups in Seoul, Busan, and Incheon with a consistent and high-quality supply of this essential co-amoxiclav antibiotic. By sourcing through our South Korea-focused logistics corridor, you benefit from optimized regional transit and competitive B2B pricing for overcoming bacterial resistance in clinical settings.

Our Regional Service Capabilities:

• East Asia: Dedicated supply and dropshipping for South Korea, Japan, China, Taiwan, and Vietnam.

• Logistics: Efficient air-freight and express delivery to major regional hubs including Incheon (ICN), Tokyo (NRT), and Shanghai (PVG).

Technical Product Specifications:

• Active Ingredients: Amoxicillin 500 mg + Clavulanic Acid 125 mg.

• Manufacturer: GMP-Certified Facilities.

• Therapeutic Class: $\beta$-lactam Antibiotic / $\beta$-lactamase Inhibitor.

• Format: Tablets.

• Clinical Utility: Moxinclav CV-625 is indicated for the treatment of various bacterial infections where $\beta$-lactamase-mediated resistance is suspected, including community-acquired pneumonia, acute exacerbations of chronic bronchitis, dental infections, and complicated urinary tract infections.

• Mechanism of Action: This formulation combines two essential components:

  1. Amoxicillin: Acts by inhibiting the final transpeptidation step of peptidoglycan synthesis in the bacterial cell wall, leading to cell lysis.

  2. Clavulanic Acid: Protects amoxicillin from degradation by $\beta$-lactamase enzymes produced by resistant bacteria, thereby extending its antimicrobial spectrum.

• Pharmacodynamics:

  1. Broad Spectrum Efficacy: Effective against a wide range of pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

  2. Overcoming Resistance: Specifically formulated to target strains that are otherwise resistant to amoxicillin alone.

  3. Bioavailability: Both components are rapidly absorbed following oral administration, with peak plasma concentrations occurring within 1 to 1.5 hours.

  4. Tissue Distribution: Exhibits excellent penetration into the middle ear fluid, lungs, and skin tissues.

The 625 mg dosage (500/125 ratio) is the therapeutic standard for adult patients, ensuring an optimal balance between high efficacy and clinical safety.

The Sky High Medex Advantage:

• Verified Quality: All batches are supplied with a comprehensive Certificate of Analysis (COA) ensuring adherence to international pharmacopeia and regional safety standards.

• Secure Logistics: Professional, medical-grade packaging with real-time tracking to ensure product integrity during transit across East Asia.

• Trade Compliance: Full documentation for smooth customs clearance (IEC & GST Certified).

• B2B Pricing: Tiered wholesale discounts available for large-scale medical centers, dental chains, and institutional healthcare networks.

📩 Direct B2B Contact

For current batch availability, tiered wholesale pricing, and shipping quotes, contact our export desk directly:

• ✅ WhatsApp: Wa.me/+919270847472

• 📧 Email: skyhighmedex@gmail.com

• 🌐 Website: www.skyhighmedexx.com